Translocation (2;3)(p21;q26) as the sole anomaly in a case of primary myelofibrosis

Cancer Genetics and Cytogenetics

Volumn 110, Issue 1, 1999, Pages 62-64

  Herens, Christian ^a   Hermanne, Jean Philippe ^a   Tassin, Francoise ^a   Fassotte, Marie France ^a   Thiry, Albert ^a   Jamar, Mauricette ^a   Schaaf Lafontaine, Nicole ^a   Fillet, Georges ^a   Koulischer, Lucien ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CASE REPORT; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION 2; CHROMOSOME TRANSLOCATION 3; CLINICAL EXAMINATION; HEPATOMEGALY; HUMAN; MALE; MYELOFIBROSIS; PRIORITY JOURNAL; SPLENECTOMY;

AGED; CHROMOSOMES, HUMAN, PAIR 2; CHROMOSOMES, HUMAN, PAIR 3; HUMANS; MALE; MYELOFIBROSIS; TRANSLOCATION, GENETIC;

EID: 0032954664     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(98)00186-1     Document Type: Article

References (14)

1. Berger R., Flexor M., Le Coniat M., Derré J., Leblanc T. Translocation (2;3)(p22;q28) is associated with myeloid disorders. Cancer Genet Cytogenet. 79:1995;130-132.
2. Prigogina E.L., Fleischman E.W., Puchkova G.P., Mayakova S.A., Protasova A.K., Frenkel M.A. Chromosomes in acute nonlymphocytic leukemia. Hum Genet. 73:1986;137-146.
3. Levaltier X., Penther D., Bastard C., Troussard X. t(2;3)(p23;q26) in a patient with AML M2. Br J Haematol. 92:1996;1026-1029.
4. Whang-Peng J., Young R.C., Lee E.C., Longo D.L., Schechter G.P., DeVita V.T. Jr. Cytogenetic studies in patients with secondary leukemia/dysmyelopoietic syndrome after different treatment modalities. Blood. 71:1988;403-414.
5. Mecucci C., Vermaelen K., Tricot G., Louwagie A., Michaux J.-L., Bosly A., Thomas J., Barbieri D., Van Den Berghe H. 3q-, 3q+ anomaly in malignant proliferations in humans. Cancer Genet Cytogenet. 9:1983;367-381.
6. Yunis J.J., Rydell R.E., Oken M.M., Arnesen M.A., Mayer M.G., Lobell M. Refined chromosome analysis as an independent prognostic indicator in de novo myelodysplastic syndrome. Blood. 67:1986;1721-1730.
7. Bitter M.A., Neilly M.E., Le Beau M.M., Pearson M.G., Rowley J.D. Rearrangements of chromosome 3 involving bands 3q21 and 3q26 are associated with normal or elevated platelet counts in acute nonlymphocytic leukemia. Blood. 66:1985;1362-1370.
8. Kwong Y.L., Chan L.C., Lie K.W. t(2;3)(p13;q26) in a case of chronic myeloid leukemia. Cancer Genet Cytogenet. 59:1992;95-96.
9. Fleischman E.W., Volkova M.A., Frenkel M.A., Konstantinova L.N., Kulagina O.E., Baranov A.E., Gordeeva A.A. Translocation (2;3)(p13;q26) in two cases of myeloid malignancies. Cancer Genet Cytogenet. 87:1996;182-184.
10. Griggs A.P., Gascoyne R.D., Phillips G.L., Horsman D.E. Clinical, hematological and cytogenetic features in 24 patients with structural rearrangements of the q arm of chromosome 3. Br J Haematol. 83:1993;158-165.
11. Fonatsch C., Gudat H., Lengfelder E., Wandt H., Silling-Engelhardt G., Ludwig W.D., Thiel E., Freund M., Bodenstein H., Schwieder G., Gruneisen A., Aul C., Schnittger S., Rieder H., Haase D., Hild F. Correlation of cytogenetic findings with clinical features in 18 patients with inv(3)(q21q26) or t(3;3)(q21;q26). Leukemia. 8:1994;1318-1326.
12. Horsman D.E., Gascoyne R.D., Barnett M.J. Acute leukemia with structural rearrangements of chromosome 3. Leukemia and Lymphoma. 16:1995;369-377.
13. Kwong Y.L. Translocation (2;3) and myeloid disorders. Cancer Genet Cytogenet. 90:1996;93.
14. Secker-Walker L.M., Metha A., Bain B. Abnormalities of 3q21 and 3q26 in myeloid malignancy. a United Kingdom Cancer Cytogenetic Group study Br J Haematol. 91:1995;490-501.